Stifel Financial
GNMK

Stifel Financial’s GenMark Diagnostics, Inc GNMK Stock Holding History

Stifel Financial’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,176
Closed -$178K – 3331
2020
Q4 		$178K Buy
12,176
+309
+3% +$4.1K ﹤0.01% 2850
2020
Q3 		$169K Sell
11,867
-4,681
-28% -$71.5K ﹤0.01% 2653
2020
Q2 		$243K Sell
16,548
-35,685
-68% -$363K ﹤0.01% 2492
2020
Q1 		$216K Buy
52,233
+26,440
+103% +$124K ﹤0.01% 2395
2019
Q4 		$126K Buy
25,793
+4,224
+20% +$23.3K ﹤0.01% 2863
2019
Q3 		$131K Buy
+21,569
New +$135K ﹤0.01% 2734

Other funds holding GNMK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stifel Financial's GNMK Position: Q1 2021 in Review

Stifel Financial sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 12,176 shares — an estimated $178K sold.

Stifel Financial first reported a position in GNMK in Q3 2019 and held it in 6 quarters. The position peaked at $243K in Q2 2020. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

  • Stifel Financial reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
  • Stifel Financial sold 12,176 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $178K.
  • Stifel Financial first reported a position in GenMark Diagnostics, Inc in Q3 2019 and held it in 6 quarters.
  • Stifel Financial's GenMark Diagnostics, Inc position peaked at $243K in Q2 2020.
  • 164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on Stifel Financial's 13F filing for Q1 2021, filed 14 May 2021.